Synthesis and molecular docking of novel non-competitive antagonists of GluK2 receptor.

Med Chem Res

Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Lab, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, ul. Chodźki 4A, 20093 Lublin, Poland.

Published: July 2014

Here we present the synthesis, pharmacological activity, and molecular docking of novel non-competitive antagonists of GluK2 receptor. The compounds concerned are derivatives of indole and carbazole and are the second reported series of non-competitive antagonists of the GluK2 receptor (the first one was also published by our group). The activity of the indole derivatives is in the micromolar range, as in the case of the first series of non-competitive GluK2 receptor antagonists. We have found that designed carbazole derivatives are devoid of activity. Active indole derivatives interact with the transduction domain of the GluK2 receptor, i.e., the domain which links the transmembrane region of the receptor with the agonist-binding domain. The binding pocket is situated within one receptor subunit.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295030PMC
http://dx.doi.org/10.1007/s00044-014-1171-1DOI Listing

Publication Analysis

Top Keywords

gluk2 receptor
20
non-competitive antagonists
12
antagonists gluk2
12
molecular docking
8
docking novel
8
novel non-competitive
8
series non-competitive
8
indole derivatives
8
receptor
7
gluk2
5

Similar Publications

Introduction: Very rarely, adult NMDAR antibody-associated encephalitis (NMDAR-E) leads to persistent cerebellar atrophy and ataxia. Transient cerebellar ataxia is common in pediatric NMDAR-E. Immune-mediated cerebellar ataxia may be associated with myelin oligodendrocyte glycoprotein (MOG), aquaporin-4 (AQP-4), kelch-like family member 11 (KLHL11), and glutamate kainate receptor subunit 2 (GluK2) antibodies, all of which may co-occur in NMDAR-E.

View Article and Find Full Text PDF

Anti-GluK2 Encephalitis in an Asian Child: A Case Report and Literature Review.

Immunotargets Ther

December 2024

Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, People's Republic of China.

Background: Anti-glutamate kainate receptor subunit 2 (anti-GluK2) antibodies mediated encephalitis is very rare in both children and adults. This study aimed to describe the second report of the anti-GluK2 encephalitis worldwide, the first youngest patient worldwide, and the first case ever in Asia. Besides, this study provides a summary of the clinical manifestations of all previous reported cases.

View Article and Find Full Text PDF

Activation of dermal mast cells through the Mas-related G protein-coupled receptor B2 receptor (MrgprB2 in mice and MrgprX2 in humans) is a key component of numerous inflammatory skin diseases, including dermatitis and rosacea. Sensory neurons actively suppress mast cell activation through the regulated release of glutamate, resulting in reduced expression of as well as genes associated with proteins found in mast cell granules. To determine whether exogenous glutamate receptor agonism could suppress mast cell function, we determined that mast cells have relatively selective expression of the glutamate receptor ionotropic, kainate 2 (GluK2).

View Article and Find Full Text PDF

α2δ-2 regulates synaptic GluK1 kainate receptors in Purkinje cells and motor coordination.

Brain

October 2024

Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Article Synopsis
  • - Gabapentin and pregabalin, drugs used for neuropathic pain and epilepsy, interact with α2δ-2 proteins in the brain, which can lead to movement disorders, but the exact mechanisms are unclear.
  • - Research showed that α2δ-2 enhances the activity of GluK1 receptors, but pregabalin reduces this enhancement, indicating a complex relationship between these proteins.
  • - The study also found that blocking GluK1 receptors affected synaptic signals in Purkinje cells, and altering the interaction between α2δ-2 and GluK1 impacted overall receptor activity, suggesting potential pathways for managing drug side effects.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!